Alzheimer\'s Drugs Market
Alzheimer\'s Drugs Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
Alzheimer\'s Drugs Market Size and Growth
The Alzheimer's drugs market is experiencing significant growth, driven by increasing prevalence and advancements in treatment options. As of 2023, the market size is projected to reach approximately $10 billion, with a compound annual growth rate (CAGR) of around 8%. Ongoing research and development efforts are crucial for future innovations.
Companies Covered
(Covid 19 Impact Covered)
◍ Johnson & Johnson
◍ Novartis
◍ Pfizer
◍ Eisai Pharmaceuticals
◍ Allergan
◍ Amgen
◍ Biogen
The Alzheimer's drugs market features key players like Johnson & Johnson, Novartis, Pfizer, Eisai, Allergan, Amgen, and Biogen, focusing on innovative treatments and collaborations. Their research and product launches drive market growth. Notably, Biogen reported $1.2 billion in sales for Alzheimer’s drugs in 2022, showcasing significant industry impact.
Market Segmentation
By Application
Under 65 Years Old
65 and Above 65 Years Old Request Sample Report
By Product
Acetylcholinesterase (AChE) Inhibitors
Glutamate Inhibitors
Other
Market Growth
Request Sample Report
$ X Billion USD
